Pharmaceutical care needs of patients with angina.
OBJECTIVE
The aim of this study was to evaluate patient knowledge and assess the management of angina for patients receiving sublingual glyceryl trinitrate (GTN) METHOD: Prospective data collection and patient interview was undertaken in 17 community pharmacies.


RESULTS
During the study 488 angina patients presented to the participating pharmacies. Data were collected for 347 patients receiving sublingual GTN. Problems with administration technique were identified for 108 patients (31%) and knowledge of when to seek medical help appropriately after failed GTN use was unsure for 134 patients (39%) or poor for 88 patients (25%). Eighty five patients (24%) were not receiving regular symptomatic therapy. Aspirin was prescribed or purchased by 253 patients (73%). Seven pharmacies participated in GP referral (data collected for 201 patients); 31 patients (15%) were referred usually with a recommendation to add aspirin. The outcome of 20 of these referrals was assessed; advice was taken for 13 patients, 3 patients failed to attend GP, aspirin was contraindicated for 3 patients and one patient already attended pharmacist medication review.


CONCLUSIONS
This study demonstrated the potential contribution community pharmacists could make at the time of dispensing to the management of patients with angina.
McGovern
E M
EM
Pharmacy Department, Stobhill Hospital, Glasgow, G21 3UW, Scotland, UK. liz@gghbpharmaud@demon.co.uk
Mackay
C
C
Hair
A
A
Lindsay
H
H
Bryson
S M
SM
D000789:Angina, Unstable / Q000188:drug therapy* / Q000453:epidemiology; D003157:Community Pharmacy Services / Q000706:statistics & numerical data*; D006801:Humans; D008485:Medical Audit / Q000706:statistics & numerical data; D005996:Nitroglycerin / Q000627:therapeutic use; D010346:Patient Care Management / Q000379:methods / Q000706:statistics & numerical data; D010353:Patient Education as Topic / Q000379:methods / Q000706:statistics & numerical data*; D011446:Prospective Studies; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D005996:Nitroglycerin